| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 1995;91:559-561.)
© 1995 American Heart Association, Inc.
Articles |
Exercise Intolerance in Heart Failure
Importance of Skeletal Muscle
From the Cardiology Division, Vanderbilt University Medical Center, Nashville, Tenn.
Correspondence to John R. Wilson, MD, Cardiology Division, RM CC-2218 MCN, Vanderbilt University Medical Center, Nashville, TN 37232-2170.
Key Words: Editorials • heart failure • muscles • exercise • respiration
 |
Introduction |
|---|
 Top Introduction References |
|---|
For over a century, investigators have sought to define the mechanisms responsible for exercise intolerance in heart failure. At the outset, this mission appeared a simple one. Exertional dyspnea was attributed to exercise-induced increases in pulmonary wedge pressure. Exertional fatigue was attributed to an inadequate cardiac output. Over the past decade, however, it has become clear that the link between cardiac dysfunction and exertional symptoms in heart failure is far more complex. This understanding has led investigators to explore novel treatment options in heart failure. In this issue of Circulation, Mancini and coworkers describe one such new treatment option: selective respiratory muscle training.
At first glance, respiratory muscle training would appear of little value since it targets the skeletal muscle rather than the circulatory system. However, recent observations increasingly suggest that abnormalities of the skeletal muscle system are important contributors to exertional symptoms in patients with heart failure. Indeed, there is growing evidence that the sensations of exertional fatigue and dyspnea are linked, in part, via the skeletal muscle system. The first evidence that noncirculatory factors contribute to exertional symptoms in heart failure came from observations that acutely altering hemodynamic parameters did not alter exertional symptoms. The traditional presumption that dyspnea is caused by elevated intrapulmonary pressures was tested by measuring symptomatic and ventilatory responses to exercise before and after pharmacologic manipulation of the pulmonary wedge pressure; excessive ventilatory levels during exercise have been viewed as a hallmark of lung dysfunction during exercise. Acute reductions in the pulmonary wedge pressure during exercise had no effect on ventilatory responses.1 Moreover, the level of excessive ventilation during exercise had no relation to the resting or exercise-induced pulmonary wedge pressure.1 2
Investigators have also noted a weak relation between flow
abnormalities and the sensation of fatigue. Although as a group
patients with heart failure have reduced leg blood flow during
exercise,3 4 a substantial number of patients with
fatigue
exhibit normal leg flow responses to exercise.5 Acute
pharmacologically induced increases in cardiac output do not improve
exertional fatigue in heart failure. A variety of interventions have
been tested, including angiotensin converting enzyme inhibitors,
-blockers, hydralazine, and inotropic
agents.6 7 8 9 10 11
In
these studies, patients typically underwent maximal exercise testing
before and after the interventions. Although such interventions
increased both cardiac output and leg blood flow, patients had no
improvement in their maximal exercise capacity, sensation of leg
fatigue, or leg lactate release.
Further evidence that exertional fatigue in heart failure is not wholly due to inadequate muscle flow comes from studies of skeletal muscle metabolism. Using 31P magnetic resonance spectroscopy, several investigators have examined forearm and calf metabolic responses to local limb exercise.12 13 14 15 16 They observed that muscle pH and phosphocreatinine concentration decreased more rapidly in patients with heart failure than in normal subjects. When flow to the exercising limb was measured, however, there was no evidence of inadequate muscle perfusion, leading to the general suspicion that the skeletal muscle of patients with heart failure is somehow altered by heart failure.
These suspicions were subsequently confirmed by biopsy studies. Several groups independently reported abnormal histochemistry and enzyme levels in the leg muscles of patients with heart failure. These abnormalities included shifts from slow-twitch to fast-twitch fiber types, atrophy of the fast-twitch type II fibers, reduced levels of mitochondrial enzymes, and reduced mitochondrial size.14 17 18 19 Minotti et al20 also noted that quadriceps muscle endurance was impaired in patients with heart failure independent of limb blood flow.
Similar abnormalities have been observed in respiratory muscle of patients with heart failure. Lindsay et al21 observed a variety of histological abnormalities in the diaphragmatic muscle of patients with heart failure. Both Hammond et al22 and McParland et al23 noted reductions in maximal inspiratory and expiratory pressures that were consistent with respiratory muscle weakness.
These observations raised the possibility that exertional symptoms in heart failure could be improved by altering skeletal muscle performance. This hypothesis was initially tested by using whole-body exercise training, an obvious intervention since the leg muscle changes noted in heart failure were thought to be caused by deconditioning. Sullivan et al24 enrolled a group of patients in a standard cardiac rehabilitation program and noted that this intervention significantly improved peak exercise oxygen consumption, skeletal muscle lactate release during exercise, and ventilatory responses to exercise. No change in hemodynamic responses to exercise was found. Coats et al25 randomized 17 patients to a home bicycle exercise program in a randomized crossover study and noted that even this unsupervised approach led to improved maximal exercise capacity, reduced ventilatory responses to exercise, and patients' subjective feelings of improvement during normal daily activities.
Mancini and coworkers sought to apply the same approach to the
respiratory muscles. In a previous study, they observed26
that maximal voluntary ventilation is decreased in patients with heart
failure, whereas diaphragmatic work during exercise is markedly
increased. They speculated, therefore, that an intervention designed to
improve the strength of respiratory muscle might reduce the sensation
of dyspnea. Their results basically support this hypothesis. Although
only a relatively small number of patients were studied, a carefully
designed respiratory muscle training regimen significantly increased
maximal inspiratory and expiratory pressure, maximal voluntary
ventilation, and both 6-minute walk time and peak exercise
O2. The effect on maximum
sustainable
ventilatory capacity was particularly striking, with average increases
of almost 50% and a dramatic reduction in the sensation of dyspnea
during the test.
Taken together, these changes represent an important finding and raise the possibility that a home-based program designed to train respiratory muscles may improve the exercise capacity of selected patients. The training program used in the study was aggressive and difficult, as shown by the fact that 6 of the 14 study patients elected to drop out of the study. However, it is possible that a less aggressive program could achieve the same results. For example, home use of a small inspiratory muscle trainer alone may have beneficial effects.
We hope that a randomized, controlled study of such a simplified regimen will be undertaken. In the meantime, it is important to emphasize that, although impressive, the findings of the present study by Mancini et al must be interpreted with caution until confirmed by additional studies. Although peak exercise capacity was improved by respiratory muscle training, the ventilatory response to exercise and the degree of dyspnea noted during bicycle exercise were unchanged. As emphasized by Mancini et al, the lack of a true control group is also cause for concern. It is possible that the improvements observed in exercise performance and symptoms were primarily due to the close attention given to the patients. Indeed, a number of placebo-controlled studies of pharmacologic agents have demonstrated improvements in exercise performance in the placebo group similar to those noted following respiratory muscle training.
Despite these potential limitations, the results of the trial are sufficiently intriguing to warrant continuing work. The results also serve to emphasize that exercise intolerance in heart failure must be viewed as a product of both skeletal muscle and cardiovascular dysfunction. To optimally treat exercise intolerance in heart failure, improving skeletal muscle characteristics may be just as important as altering the cardiovascular system.
|
Footnotes |
|---|
The opinions expressed in this editorial are not necessarily those of the editors or of the American Heart Association.
|
References |
|---|
|
TopIntroductionReferences |
|---|
1. Fink LI, Wilson JR, Ferraro N. Exercise ventilation and pulmonary artery wedge pressure in chronic stable congestive heart failure. Am J Cardiol. 1986;57:249-253. [Medline] [Order article via Infotrieve]
2.
Sullivan MJ, Higginbotham MB, Cobb FR. Increased exercise
ventilation in patients with chronic heart failure: intact ventilatory
control despite hemodynamic and pulmonary abnormalities.
Circulation. 1988;77:552-559.
3.
Wilson JR, Martin JL, Schwartz D, Ferraro N. Exercise
intolerance in patients with chronic heart failure: role of impaired
nutritive flow to skeletal muscle. Circulation. 1984;69:1079-1087.
4.
Sullivan MJ, Knight JD, Higginbotham MB, Cobb FR. Relation
between central and peripheral hemodynamics during exercise in patients
with chronic heart failure. Circulation. 1989;80:769-781.
5.
Wilson JR, Mancini DM, Dunkman WB. Exertional fatigue due to
skeletal muscle dysfunction in patients with heart failure.
Circulation. 1993;87:470-475.
6. Wilson JR, Martin JL, Ferraro N. Impaired skeletal muscle nutritive flow during exercise in patients with heart failure: role of cardiac pump dysfunction as determined by effect of dobutamine. Am J Cardiol. 1984;54:1308-1315.
7.
Wilson JR, Martin JL, Ferraro N, Weber KT. Effect of
hydralazine on perfusion and metabolism during upright bicycle exercise
in patients with heart failure. Circulation. 1983;68:425-432.
8.
Wilson JR, Ferraro N, Wiener DH. Effect of the sympathetic
nervous system on limb circulation and metabolism during exercise in
heart failure. Circulation. 1985;72:72-81.
9. Wilson JR, Ferraro N. Effect of the renin-angiotensin system on limb circulation and metabolism during exercise in heart failure. J Am Coll Cardiol. 1985;6:556-563. [Abstract]
10.
Drexler H, Banhardt U, Meinertz T, Wollschlager H, Lehmann M,
Just H. Contrasting peripheral short-term and long-term effects of
converting enzyme inhibition in patients with congestive heart failure.
Circulation. 1989;79:491-502.
11. Maskin CS, Kugler J, Sonnenblick EH, LeJemtel TH. Acute inotropic stimulation with dopamine in severe congestive heart failure: beneficial hemodynamic effect at rest but not during maximal exercise. Am J Cardiol. 1983;52:1028-1032. [Medline] [Order article via Infotrieve]
12.
Wilson JR, Fink L, Maris J, Ferraro N, Power-Vanwart J, Eleff
S, Chance B. Evaluation of energy metabolism in skeletal muscle of
patients with heart failure with gated phosphorus-31 nuclear magnetic
resonance. Circulation. 1985;71:57-62.
13.
Wiener DH, Fink LI, Maris J, Jones RA, Chance B, Wilson
JR. Abnormal skeletal muscle bioenergetics during exercise in heart
failure: role of reduced muscle blood flow.
Circulation. 1986;73:1127-1136.
14.
Mancini DM, Coyle E, Coggan A, Beltz J, Ferraro N, Montain S,
Wilson JR. Contribution of intrinsic skeletal muscle changes to 31P NMR
skeletal muscle metabolic abnormalities in patients with chronic heart
failure. Circulation. 1989;80:1338-1346.
15. Mancini DM, Ferraro N, Tuchler M, Chance B, Wilson JR. Detection of abnormal calf muscle metabolism in patients with heart failure using phosphorus-31 nuclear magnetic resonance. Am J Cardiol. 1988;62:1234-1240. [Medline] [Order article via Infotrieve]
16.
Massie B, Conway M, Yonge R, Frostick S, Ledingham J, et al.
Skeletal muscle metabolism in patients with congestive heart failure:
relation to clinical severity and blood flow.
Circulation. 1987;76:1009-1019.
17.
Mancini DM, Walter G, Reichek N, Lenkinski R, McCully KK,
Mullen JL, Wilson JR. Contribution of skeletal muscle atrophy to
exercise intolerance and altered muscle metabolism in heart failure.
Circulation. 1992;85:1364-1373.
18.
Sullivan MJ, Green HJ, Cobb FR. Skeletal muscle biochemistry
and histology in ambulatory patients with long-term heart failure.
Circulation. 1990;81:518-527.
19.
Drexler H, Riede U, Munzel T, Konig H, et al.
Alterations of skeletal muscle in chronic heart failure.
Circulation. 1992;85:1751-1759.
20. Minotti JR, Christoph I, Oka R, Weiner MW, Wells L, Massie BM. Impaired skeletal muscle function in patients with congestive heart failure. J Clin Invest. 1991;88:2077-2082.
21. Lindsay D, Lovegrove C, Dunn M, Bennett JG, et al. Histological abnormalities of diaphragmatic muscle may contribute to dyspnea in heart failure. Circulation. 1992;86:515A. Abstract.
22.
Hammond M, Bauer K, Sharp J, Rocha R. Respiratory muscle
strength in congestive heart failure. Chest. 1990;98:1091-1094.
23. McParland C, Krishnan B, Wang Y, Gallager C. Inspiratory muscle weakness and dyspnea in chronic heart failure. Am Rev Respir Dis. 1992;146:467-472. [Medline] [Order article via Infotrieve]
24.
Sullivan MJ, Higginbotham MB, Cobb FR. Exercise training in
patients with chronic heart failure delays ventilatory anaerobic
threshold and improves submaximal exercise performance.
Circulation. 1989;79:324-329.
25.
Coats AJS, Adamopoulos S, Radaelli A, McCance A, et al.
Controlled trial of physical training in chronic heart failure.
Circulation. 1992;85:2119-2131.
26.
Mancini DM, Henson D, LaManca J, Levine S. Respiratory muscle
function and dyspnea in patients with chronic congestive heart failure.
Circulation. 1992;86:909-918.
This article has been cited by other articles:
 |
|
 |
|
  H. Tsutsui, S. Kinugawa, and S. Matsushima Mitochondrial oxidative stress and dysfunction in myocardial remodelling Cardiovasc Res, February 15, 2009; 81(3): 449 - 456. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. G. Allen, G. D. Lamb, and H. Westerblad Skeletal Muscle Fatigue: Cellular Mechanisms Physiol Rev, January 1, 2008; 88(1): 287 - 332. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Lawler, H.-B. Kwak, W. Song, and J. L. Parker Exercise training reverses downregulation of HSP70 and antioxidant enzymes in porcine skeletal muscle after chronic coronary artery occlusion Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2006; 291(6): R1756 - R1763. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kinugawa, Z. Wang, P. M. Kaminski, M. S. Wolin, J. G. Edwards, G. Kaley, and T. H. Hintze Limited Exercise Capacity in Heterozygous Manganese Superoxide Dismutase Gene-Knockout Mice: Roles of Superoxide Anion and Nitric Oxide Circulation, March 29, 2005; 111(12): 1480 - 1486. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Gonzalez-Serratos, R. Chang, E. F. R. Pereira, N. G. Castro, Y. Aracava, P. A. Melo, P. C. Lima, C. A. M. Fraga, E. J. Barreiro, and E. X. Albuquerque A Novel Thienylhydrazone, (2-Thienylidene)3,4-methylenedioxybenzoylhydrazine, Increases Inotropism and Decreases Fatigue of Skeletal Muscle J. Pharmacol. Exp. Ther., November 1, 2001; 299(2): 558 - 566. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Tsutsui, T. Ide, S. Hayashidani, N. Suematsu, T. Shiomi, J. Wen, K.-i. Nakamura, K. Ichikawa, H. Utsumi, and A. Takeshita Enhanced Generation of Reactive Oxygen Species in the Limb Skeletal Muscles From a Murine Infarct Model of Heart Failure Circulation, July 10, 2001; 104(2): 134 - 136. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. T. Pu, M. T. Johnson, D. E. Forman, J. M. Hausdorff, R. Roubenoff, M. Foldvari, R. A. Fielding, and M. A. F. Singh Randomized trial of progressive resistance training to counteract the myopathy of chronic heart failure J Appl Physiol, June 1, 2001; 90(6): 2341 - 2350. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. L. Jones and K. J. Killian Exercise Limitation in Health and Disease N. Engl. J. Med., August 31, 2000; 343(9): 632 - 641. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Chauhan, G. Sridhar, R. Clemens, B. Krishnan, D. D. Marciniuk, and C. G. Gallagher Role of Respiratory Function in Exercise Limitation in Chronic Heart Failure Chest, July 1, 2000; 118(1): 53 - 60. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Yajid, J. G. Mercier, B. M. Mercier, H. Dubouchaud, and C. Prefaut Effects of 4 wk of hindlimb suspension on skeletal muscle mitochondrial respiration in rats J Appl Physiol, February 1, 1998; 84(2): 479 - 485. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. G. Peters, H. L. Mitchell, S. A. McCune, S. Park, J. H. Williams, and S. C. Kandarian Skeletal Muscle Sarcoplasmic Reticulum Ca2+-ATPase Gene Expression in Congestive Heart Failure Circ. Res., November 19, 1997; 81(5): 703 - 710. [Abstract] [Full Text]
|
|
|
|
|
|
P. K. Lunde, A. J. Dahlstedt, J. D. Bruton, J. Lannergren, P. Thoren, O. M. Sejersted, and H. Westerblad Contraction and Intracellular Ca2+ Handling in Isolated Skeletal Muscle of Rats With Congestive Heart Failure Circ. Res., June 22, 2001; 88(12): 1299 - 1305. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||